CAR-NK Cells (CL-NK-003) in Pancreatic Cancer

This is a single-center, open-label, first-in-human, fixed-dose study in patients with pancreatic cancer.

Trial Details

NCT ID
NCT07425483
Phase
PHASE1
Sponsor
Changhai Hospital
Status
RECRUITING
Cancer Type
Pancreatic Cancer
Interventions
  • CL-NK-003
Locations (sample)
  • Shanghai, China|31.22222,121.45806

Key Eligibility Criteria

  • 1\. Aged 18-75 years;2. Locally advanced, metastatic, or recurrent pancreatic cancer, with immunohistochemical detection of eGR1 (membrane positive…

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Pancreatic Cancer Trials on Trialify →